title: SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985.
abstract: During leptin signaling, each of the phosphorylated tyrosine residues on the long form of the leptin receptor (LRb) mediates distinct signals. Phosphorylated Tyr(1138) binds STAT3 to mediate its tyrosine phosphorylation and transcriptional activation, while phosphorylated Tyr(985) binds the tyrosine phosphatase SHP-2 and reportedly mediates both activation of ERK kinases and inhibition of LRb-mediated STAT3 activation. We show here that although mutation of Tyr(985) does not alter STAT3 signaling by erythropoietin receptor-LRb (ELR) chimeras in transfected 293 cells at short times of stimulation, this mutation enhances STAT3 signaling at longer times of stimulation (>6 h). These data suggest that Tyr(985) may mediate feedback inhibition of LRb signaling by an LRb-induced LRb inhibitor, such as SOCS3. Indeed, SOCS3 binds specifically to phosphorylated Tyr(985) of LRb, and SOCS3 fails to inhibit transcription by ELR following mutation of Tyr(985), suggesting that SOCS3 inhibits LRb signaling by binding to phosphorylated Tyr(985). Additionally, overexpression of SOCS3, but not SHP-2, impairs ELR signaling, and the overexpression of SHP-2 blunts SOCS3-mediated inhibition of ELR signaling. Thus, our data suggest that in addition to mediating SHP-2 binding and ERK activation during acute stimulation, Tyr(985) of LRb mediates feedback inhibition of LRb signaling by binding to LRb-induced SOCS3.
authors.affiliation: Division of Endocrinology, Beth Israel-Deaconess Medical Center, Harvard Medical School, and Section on Obesity, Research Division, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
authors.forename: C
authors.initials: C
authors.lastname: Bjorbak
authors.forename: H J
authors.initials: HJ
authors.lastname: Lavery
authors.forename: S H
authors.initials: SH
authors.lastname: Bates
authors.forename: R K
authors.initials: RK
authors.lastname: Olson
authors.forename: S M
authors.initials: SM
authors.lastname: Davis
authors.forename: J S
authors.initials: JS
authors.lastname: Flier
authors.forename: M G
authors.initials: MG
authors.lastname: Myers
mesh_terms: D002352:Carrier Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry; D002460:Cell Line; D005246:Feedback; D006801:Humans; D011506:Proteins / Q000502:physiology*; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D012097:Repressor Proteins; D015398:Signal Transduction; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins; D014157:Transcription Factors; D014443:Tyrosine / Q000378:metabolism*
chemical_list: D002352:Carrier Proteins; C515448:LEPR protein, human; D011506:Proteins; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D012097:Repressor Proteins; C106644:SOCS3 protein, human; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins; D014157:Transcription Factors; D014443:Tyrosine